Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentcytoplasmic ribonucleoprotein granule

LIMD1 PABPC1 DAZAP2 CNOT3 EIF4G1

9.46e-06269235GO:0036464
GeneOntologyCellularComponentribonucleoprotein granule

LIMD1 PABPC1 DAZAP2 CNOT3 EIF4G1

1.29e-05287235GO:0035770
GeneOntologyCellularComponentcytoplasmic stress granule

PABPC1 DAZAP2 EIF4G1

1.56e-0496233GO:0010494
GeneOntologyCellularComponentadherens junction

LIMD1 PLEKHA7 PARD3B

1.57e-03212233GO:0005912
GeneOntologyCellularComponentsomatodendritic compartment

VGF SHISA9 PABPC1 PRSS12 IGSF9B MAPK8IP3

1.72e-031228236GO:0036477
GeneOntologyCellularComponentdendrite

SHISA9 PABPC1 PRSS12 IGSF9B MAPK8IP3

2.09e-03858235GO:0030425
GeneOntologyCellularComponentdendritic tree

SHISA9 PABPC1 PRSS12 IGSF9B MAPK8IP3

2.11e-03860235GO:0097447
DomainIGv

CD28 IGSF9B

3.81e-0375232SM00406
DomainPDZ

PARD3B SYNPO2L

1.29e-02141232PF00595
DomainPDZ

PARD3B SYNPO2L

1.41e-02148232SM00228
Domain-

PARD3B SYNPO2L

1.45e-021502322.30.42.10
DomainPDZ

PARD3B SYNPO2L

1.47e-02151232PS50106
DomainPDZ

PARD3B SYNPO2L

1.49e-02152232IPR001478
PathwayREACTOME_DEADENYLATION_OF_MRNA

PABPC1 CNOT3 EIF4G1

4.13e-0624193MM15090
PathwayREACTOME_DEADENYLATION_OF_MRNA

PABPC1 CNOT3 EIF4G1

4.69e-0625193M13492
PathwayREACTOME_M_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_MATERNALLY_STORED_FACTORS

PABPC1 CNOT3 EIF4G1

1.10e-0533193M48026
PathwayREACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY

PABPC1 CNOT3 EIF4G1

4.93e-0554193MM15089
PathwayREACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY

PABPC1 CNOT3 EIF4G1

5.50e-0556193M839
PathwayREACTOME_Z_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_ZYGOTICALLY_EXPRESSED_FACTORS

PABPC1 EIF4G1

1.13e-0412192M48027
PathwayBIOCARTA_EIF4_PATHWAY

PABPC1 EIF4G1

4.67e-0424192M4791
PathwayREACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT

PABPC1 CNOT3 EIF4G1

6.37e-04128193M48019
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

LIMD1 WNK1 TET2 PLEKHA7 PABPC1 PARD3B NCOA6 AQR TAB3 EIF4G1

7.02e-11861231036931259
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

RNF38 WNK1 PLEKHA7 PABPC1 NCOA6 IGSF9B

2.91e-0743023635044719
Pubmed

Epstein-Barr Virus Protein EB2 Stimulates Translation Initiation of mRNAs through Direct Interactions with both Poly(A)-Binding Protein and Eukaryotic Initiation Factor 4G.

PABPC1 EIF4G1

4.18e-07223229142127
Pubmed

Poly(A) binding protein abundance regulates eukaryotic translation initiation factor 4F assembly in human cytomegalovirus-infected cells.

PABPC1 EIF4G1

4.18e-07223222431630
Pubmed

Recognition of eIF4G by rotavirus NSP3 reveals a basis for mRNA circularization.

PABPC1 EIF4G1

4.18e-07223212086624
Pubmed

A mechanism of translational repression by competition of Paip2 with eIF4G for poly(A) binding protein (PABP) binding.

PABPC1 EIF4G1

4.18e-07223216772376
Pubmed

Interdomain allostery promotes assembly of the poly(A) mRNA complex with PABP and eIF4G.

PABPC1 EIF4G1

4.18e-07223223041282
Pubmed

BRCA1-Dependent Translational Regulation in Breast Cancer Cells.

PABPC1 EIF4G1

1.25e-06323223805307
Pubmed

Proteomics of herpes simplex virus infected cell protein 27: association with translation initiation factors.

PABPC1 EIF4G1

1.25e-06323215567442
Pubmed

Nuclear localization of cytoplasmic poly(A)-binding protein upon rotavirus infection involves the interaction of NSP3 with eIF4G and RoXaN.

PABPC1 EIF4G1

1.25e-06323218799579
Pubmed

A newly identified N-terminal amino acid sequence of human eIF4G binds poly(A)-binding protein and functions in poly(A)-dependent translation.

PABPC1 EIF4G1

1.25e-0632329857202
Pubmed

DEAD-box protein DDX3 associates with eIF4F to promote translation of selected mRNAs.

PABPC1 EIF4G1

2.51e-06423222872150
Pubmed

Assembly of AUF1 with eIF4G-poly(A) binding protein complex suggests a translation function in AU-rich mRNA decay.

PABPC1 EIF4G1

2.51e-06423216556936
Pubmed

Neural RNA-binding protein Musashi1 inhibits translation initiation by competing with eIF4G for PABP.

PABPC1 EIF4G1

2.51e-06423218490513
Pubmed

Proline-rich transcript in brain protein induces stress granule formation.

DAZAP2 EIF4G1

2.51e-06423217984221
Pubmed

Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouse.

CD28 PARD3B

4.18e-06523215210771
Pubmed

HIV- 1 protease inhibits Cap- and poly(A)-dependent translation upon eIF4GI and PABP cleavage.

PABPC1 EIF4G1

4.18e-06523219956697
Pubmed

eIF4E-bound mRNPs are substrates for nonsense-mediated mRNA decay in mammalian cells.

PABPC1 EIF4G1

8.77e-06723223665581
Pubmed

Control of mRNA decay by heat shock-ubiquitin-proteasome pathway.

PABPC1 EIF4G1

8.77e-06723210205060
Pubmed

Cadherin complexes recruit mRNAs and RISC to regulate epithelial cell signaling.

PLEKHA7 PABPC1

8.77e-06723228877994
Pubmed

NEDDylation promotes stress granule assembly.

PABPC1 EIF4G1

1.88e-051023227381497
Pubmed

The RNA helicase Ddx5/p68 binds to hUpf3 and enhances NMD of Ddx17/p72 and Smg5 mRNA.

PABPC1 EIF4G1

1.88e-051023223788676
Pubmed

miRNA-mediated deadenylation is orchestrated by GW182 through two conserved motifs that interact with CCR4-NOT.

PABPC1 CNOT3

1.88e-051023221984185
Pubmed

UBAP2L arginine methylation by PRMT1 modulates stress granule assembly.

PABPC1 EIF4G1

1.88e-051023231114027
Pubmed

miRNA repression involves GW182-mediated recruitment of CCR4-NOT through conserved W-containing motifs.

PABPC1 CNOT3

2.29e-051123221984184
Pubmed

Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.

TET2 PABPC1 AQR TAB3 EIF4G1

2.60e-0555123534728620
Pubmed

Human transcription factor protein interaction networks.

LIMD1 TET2 PABPC1 NCOA6 CNOT3 TAB3 EIF4G1

2.67e-05142923735140242
Pubmed

G3BP-Caprin1-USP10 complexes mediate stress granule condensation and associate with 40S subunits.

PABPC1 EIF4G1

2.75e-051223227022092
Pubmed

Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation.

PABPC1 EIF4G1

3.79e-051423219716330
Pubmed

Targeting a complex transcriptome: the construction of the mouse full-length cDNA encyclopedia.

RNF38 AQR SYNPO2L EIF4G1

3.80e-0529223412819125
Pubmed

GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets.

PABPC1 CNOT3

4.37e-051523221981923
Pubmed

Temporally defined neocortical translation and polysome assembly are determined by the RNA-binding protein Hu antigen R.

PABPC1 EIF4G1

1.14e-042423225157170
Pubmed

Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.

LIMD1 WNK1 PABPC1 CAPNS1

1.27e-0439923435987950
Pubmed

The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.

TET2 TAB3 EYA1

1.36e-0415223338360978
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

RNF38 TET2 DAZAP2 CNOT3 MAPK8IP3 EIF4G1

1.48e-04128523635914814
Pubmed

Host PDZ-containing proteins targeted by SARS-CoV-2.

PARD3B SYNPO2L

2.46e-043523233864728
Pubmed

14-3-3 proteins sequester a pool of soluble TRIM32 ubiquitin ligase to repress autoubiquitylation and cytoplasmic body formation.

WNK1 PLEKHA7

3.54e-044223223444366
Pubmed

Roquin promotes constitutive mRNA decay via a conserved class of stem-loop recognition motifs.

PABPC1 CNOT3

4.07e-044523223663784
Pubmed

Mitotic phosphorylation of eukaryotic initiation factor 4G1 (eIF4G1) at Ser1232 by Cdk1:cyclin B inhibits eIF4A helicase complex binding with RNA.

PABPC1 EIF4G1

4.83e-044923224248602
Pubmed

Integrative genomics positions MKRN1 as a novel ribonucleoprotein within the embryonic stem cell gene regulatory network.

PABPC1 EIF4G1

5.44e-045223226265008
Pubmed

Functional proteomics mapping of a human signaling pathway.

LIMD1 DAZAP2 NCOA6 EIF4G1

5.65e-0459123415231748
Pubmed

The RNA-binding ubiquitin ligase MKRN1 functions in ribosome-associated quality control of poly(A) translation.

PABPC1 IGSF9B

6.08e-045523231640799
Pubmed

Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.

WNK1 PABPC1 PARD3B

6.19e-0425523315324660
InteractionYWHAG interactions

LIMD1 WNK1 TET2 PLEKHA7 PABPC1 PARD3B NCOA6 AQR TAB3 CAPNS1 EIF4G1

3.33e-0812482311int:YWHAG
InteractionYWHAH interactions

LIMD1 WNK1 TET2 PLEKHA7 PARD3B NCOA6 AQR TAB3 CAPNS1 EIF4G1

1.37e-0711022310int:YWHAH
InteractionSFN interactions

WNK1 TET2 PLEKHA7 PABPC1 PARD3B NCOA6 TAB3 EIF4G1

5.76e-07692238int:SFN
InteractionYWHAQ interactions

WNK1 TET2 PLEKHA7 PARD3B NCOA6 TAB3 CAPNS1 EIF4G1

2.03e-051118238int:YWHAQ
CytobandEnsembl 112 genes in cytogenetic band chr2q33

CD28 PARD3B

4.72e-03205232chr2q33
CytobandEnsembl 112 genes in cytogenetic band chr16p13

SHISA9 MAPK8IP3

1.91e-02426232chr16p13
GeneFamilyPDZ domain containing

PARD3B SYNPO2L

1.09e-021521921220
GeneFamilyAdenosine receptors|V-set domain containing

CD28 IGSF9B

1.25e-02163192590
ToppCellPBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters

LIMD1 WNK1 PABPC1 CAPNS1

2.90e-0619623409d197b321ff9f13c0672ea059c850845b0dbbd5
ToppCellControl-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class

WNK1 PLEKHA7 CD28 PARD3B

3.02e-06198234ee71543559836fd59adc0da877b2ca538cba60cb
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

SHISA9 PLEKHA7 ADAMTSL2

5.54e-05145233b17699f7f98d2361a4d26c26f52db05e7ff69dff
ToppCellCOVID-19_Moderate-MAIT|World / disease group, cell group and cell class

PLEKHA7 CD28 IGSF9B

7.42e-05160233bf73c5fe87c1f243edec17d7a2c30fae5e2cfd6b
ToppCellPCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

SHISA9 IGSF9B EYA1

8.42e-0516723349b19159c62d33d65ed1e59a148c11ae902fd41c
ToppCellwk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

SHISA9 IGSF9B EYA1

1.00e-041772335357359e6c2161a37f39a6b3b78449f5cbc327d1
ToppCellnormal-na-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

PABPC1 PRSS12 CD28

1.02e-04178233fa3585383a1e7da460c88a802aaa81246d681b6b
ToppCellPCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

SHISA9 IGSF9B EYA1

1.10e-04183233e0854864d377e158a4793088d1cb6b3dbf2c805d
ToppCell10x5'v1-week_17-19-Lymphocytic_T-T_NK-Treg|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

CD28 NCOA6 IGSF9B

1.10e-041832335fb933acfe6bc555c90dba71e75d4be658763945
ToppCellPCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

SHISA9 IGSF9B EYA1

1.14e-0418523356c7a0dbf141728ac76b8c90af197719942ca67c
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SHISA9 PARD3B EYA1

1.20e-0418823363a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCellPCW_13-14|World / Celltypes from embryonic and fetal-stage human lung

LIMD1 PRSS12 PARD3B

1.23e-0419023362a3ec1ae0829602b0569cc051210551644f1d46
ToppCell10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

PABPC1 CAPNS1 EIF4G1

1.35e-0419623328e9e191361966df3a9bd48450090577aa72a999
ToppCellCOVID-19_Convalescent-Classical_Monocyte-cMono_2|COVID-19_Convalescent / Disease condition and Cell class

PABPC1 DAZAP2 CAPNS1

1.39e-04198233f65fd9b773aeafa55e38309479954a8e41371f52
ToppCellParenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PLEKHA7 PRSS12 EYA1

1.39e-041982331408e02e053ad3406229bfe8189da03be6366e81
ToppCellParenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PLEKHA7 PRSS12 EYA1

1.39e-04198233af399569c718f5fd971d73a7926768c9311002a3
ToppCellCOVID-19_Convalescent-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class

PABPC1 DAZAP2 CAPNS1

1.41e-041992333feee9f53860b4b2e93ff2360beb2b2b74f51d24
ToppCellNeuronal-Inhibitory-iB-iB_1(GAD1)-GLP1R--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic

VGF PLEKHA7 PARD3B

1.44e-04200233cdc43730334f8f623d936469acbae00a67c13a7b
ToppCellNeuronal-Inhibitory-iB-iB_1(GAD1)|Neuronal / cells hierarchy compared to all cells using T-Statistic

VGF PLEKHA7 PARD3B

1.44e-042002336c16151567ef100296f7c12cde350fc6ce146745
ToppCellNeuronal-Inhibitory-iB-iB_1(GAD1)-GLP1R-|Neuronal / cells hierarchy compared to all cells using T-Statistic

VGF PLEKHA7 PARD3B

1.44e-042002336b1c0176fe2ec6baedae44a7b330c2b32eea25cb
ToppCellH1299|World / Cell line, Condition and Strain

VGF WNK1 PABPC1

1.44e-0420023323f08d7cffacfced48785cd3ad230ecadb95713f
ToppCellNeuronal-Inhibitory-iB-iB_1(GAD1)-GLP1R|Neuronal / cells hierarchy compared to all cells using T-Statistic

VGF PLEKHA7 PARD3B

1.44e-042002337da0ccfcd024842ad85f34b523ead6ec61f7e864
DiseasePeripheral T-Cell Lymphoma

TET2 CD28

2.61e-0510232C0079774
DiseaseSezary Syndrome

TET2 CD28

2.02e-0427232C0036920
Diseasecortical surface area measurement

TET2 PLEKHA7 PRSS12 CD28 PARD3B EYA1

4.58e-041345236EFO_0010736
Diseaseautism

PARD3B EYA1

6.41e-0448232EFO_0003758
Diseasecalcium measurement

TET2 PABPC1 NCOA6 EYA1

1.30e-03628234EFO_0004838
Diseaserheumatoid arthritis (is_marker_for)

CD28 TAB3

1.32e-0369232DOID:7148 (is_marker_for)
Diseasevitamin D measurement

VGF PLEKHA7 CNOT3

2.19e-03336233EFO_0004631
Diseasehypertrophic cardiomyopathy

PARD3B SYNPO2L

2.33e-0392232EFO_0000538
Diseaseattention deficit hyperactivity disorder, autism spectrum disorder, intelligence

SHISA9 TET2 IGSF9B

3.53e-03398233EFO_0003756, EFO_0003888, EFO_0004337
Diseasemelanoma

TET2 NCOA6

4.32e-03126232EFO_0000756
Diseasesleep measurement

TET2 EYA1

4.94e-03135232EFO_0004870

Protein segments in the cluster

PeptideGeneStartEntry
PRRPGPTRKHYQPYA

CD28

196

P10747
PHVIPNRGPYPYNQP

AQR

781

O60306
QYLPRNPCPTPPYHH

CNOT3

636

O75175
AYYPPSQIAQLRPSP

PABPC1

421

P11940
DLRYPQHYPPPPAPQ

PARD3B

1136

Q8TEW8
PVYPQTLHLPQAPPY

DAZAP2

21

Q15038
PHYPYYLPTQQRPPR

PRSS12

41

P56730
PPPAKRPYPSVNIHY

MAPK8IP3

586

Q9UPT6
PYPPQEQRSRPYLHG

LIMD1

126

Q9UGP4
PRPTHQFSPPQIYPS

EYA1

76

Q99502
QFSPPQIYPSNRPYP

EYA1

81

Q99502
QIYPSNRPYPHILPT

EYA1

86

Q99502
LQPPHESRPQPIYYG

ADAMTSL2

331

Q86TH1
TPNRASPRPYYPQTP

NCOA6

1211

Q14686
YNPEPPPPRTHYSNI

CAPNS1

76

P04632
QPRQHFYPSRAQPPS

EIF4G1

46

Q04637
YSPNIRAPPPIAYNP

SYNPO2L

801

Q9H987
SRYRSQQPIPPPPYH

RNF38

371

Q9H0F5
GPYHPFPNYIRPRTL

VGF

541

O15240
GPVPHYSQRPLPVYP

TAB3

256

Q8N5C8
LFPQLQTYVPYRPHP

PLEKHA7

881

Q6IQ23
QTYVPYRPHPPQLRK

PLEKHA7

886

Q6IQ23
GTRPQHYPPPQPYFI

SHISA9

401

B4DS77
SYLPPPAYSPRFQPR

IGSF9B

921

Q9UPX0
VLYQGFPPRLPPQYP

WNK1

941

Q9H4A3
TNPYMRRPNPVSPYP

TET2

1566

Q6N021